Case Report
BibTex RIS Cite
Year 2021, Volume: 12 Issue: 3, 85 - 87, 18.08.2021
https://doi.org/10.33706/jemcr.885104

Abstract

References

  • Varadhachary GR. Carcinoma of unknown primary origin. Gastrointestinal cancer research : GCR 2007;1:229-35.
  • Dermawan JK, Rubin BP. The role of molecular profiling in the diagnosis and management of metastatic undifferentiated cancer of unknown primary(✰): Molecular profiling of metastatic cancer of unknown primary. Seminars in diagnostic pathology 2020.
  • Qaseem A, Usman N, Jayaraj JS, Janapala RN, Kashif T. Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients with the Unknown Primary Site. Cureus 2019;11:e5552.
  • Natoli C, Ramazzotti V, Nappi O et al. Unknown primary tumors. Biochimica et biophysica acta 2011;1816:13-24.
  • Massard C, Loriot Y, Fizazi K. Carcinomas of an unknown primary origin--diagnosis and treatment. Nature reviews Clinical oncology 2011;8:701-10.
  • Page Widick AMB, Fred Schiffman,. Hematology (Seventh Edition: Elsevier, 2018.
  • Kilickap S, Erman M, Dincer M, Aksoy S, Harputluoglu H, Yalcin S. Bone marrow metastasis in solid tumors: Clinical evaluation of 64 cases. 2005;23:8270-8270.
  • Wong KF, Chan JK, Ma SK. Solid tumour with initial presentation in the bone marrow--a clinicopathologic study of 25 adult cases. Hematological oncology 1993;11:35-42.
  • Ringenberg QS, Doll DC, Yarbro JW, Perry MC. Tumors of unknown origin in the bone marrow. Archives of internal medicine 1986;146:2027-8.
  • Ryan RN, Ware WH. Common dental emergencies which may be encountered by the family physician. The Journal of family practice 1975;2:249-53.
  • Fishpool SJ, Tomkinson A. Patterns of hospital admission with epistaxis for 26,725 patients over an 18-year period in Wales, UK. Annals of the Royal College of Surgeons of England 2012;94:559-62.
  • Izak M, Bussel JB. Management of thrombocytopenia. F1000prime reports 2014;6:45.
  • Chou WC, Yeh KY, Peng MT et al. Development and Validation of a Prognostic Score to Predict Survival in Adult Patients With Solid Tumors and Bone Marrow Metastases. Medicine 2015;94:e966.
  • Lee MS, Sanoff HK. Cancer of unknown primary. BMJ (Clinical research ed) 2020;371:m4050.
  • Chandra S, Chandra H, Saini S. Bone marrow metastasis by solid tumors--probable hematological indicators and comparison of bone marrow aspirate, touch imprint and trephine biopsy. Hematology (Amsterdam, Netherlands) 2010;15:368-72.
  • Sar R, Aydogdu I, Ozen S, Sevinc A, Buyukberber S. Metastatic bone marrow tumours: a report of six cases and review of the literature. Haematologia 2001;31:215-23.

Common Symptom, Rare Etiology: A Case Metastatic Cancers of Unknown Primary Origin Presenting with Epistaxis and Gingival Bleeding

Year 2021, Volume: 12 Issue: 3, 85 - 87, 18.08.2021
https://doi.org/10.33706/jemcr.885104

Abstract

Introduction
Epistaxis and gingival bleeding are among the most common presentation to the emergency department for patients with thrombocytopenia. Here, we present a case who was admitted to the emergency department with thrombocytopenia and was diagnosed with metastatic cancer of unknown primary
origin.

Case
A 26-year-old male patient was admitted to the emergency department with gingival bleeding and epistaxis. The body temperature was 38.3 °C. Petechial rash, ecchymosis or organomegaly was not detected on physical examination. Laboratory results revealed thrombocytopenia as 31x 10³ (159-388
x 10³/μL). Although hemoglobin and leukocyte counts were normal, no band or precursor cell was observed in the patient's peripheral blood smear. There was no history of weight loss, night sweats, arthritis, malar rash, photosensitivity, contact with ticks, animals, or a COVID-19 patient. Serological tests performed for infections such as HIV, EBV, HCV, Crimean-Congo hemorrhagic fever were negative. Bone marrow biopsy was performed due to the unexplained cytopenia, reported as "signet ring cell metastatic adenocarcinoma". Gastrointestinal system endoscopy was performed to detect primary cancer. A biopsy was taken from the antrum and corpus revealed gastritis. An FDG PET-CT was revealed heterogeneously pathologically increased FDG attitude in all axial and appendicular bones. Despite all the modalities of diagnosis, the origin was not found and the patient was transferred to the oncology department for treatment with a diagnosis of cancer of unknown origin with bone marrow infiltration.

Conclusions
Bone marrow metastases should be kept in mind in patients presenting with thrombocytopenia.

References

  • Varadhachary GR. Carcinoma of unknown primary origin. Gastrointestinal cancer research : GCR 2007;1:229-35.
  • Dermawan JK, Rubin BP. The role of molecular profiling in the diagnosis and management of metastatic undifferentiated cancer of unknown primary(✰): Molecular profiling of metastatic cancer of unknown primary. Seminars in diagnostic pathology 2020.
  • Qaseem A, Usman N, Jayaraj JS, Janapala RN, Kashif T. Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients with the Unknown Primary Site. Cureus 2019;11:e5552.
  • Natoli C, Ramazzotti V, Nappi O et al. Unknown primary tumors. Biochimica et biophysica acta 2011;1816:13-24.
  • Massard C, Loriot Y, Fizazi K. Carcinomas of an unknown primary origin--diagnosis and treatment. Nature reviews Clinical oncology 2011;8:701-10.
  • Page Widick AMB, Fred Schiffman,. Hematology (Seventh Edition: Elsevier, 2018.
  • Kilickap S, Erman M, Dincer M, Aksoy S, Harputluoglu H, Yalcin S. Bone marrow metastasis in solid tumors: Clinical evaluation of 64 cases. 2005;23:8270-8270.
  • Wong KF, Chan JK, Ma SK. Solid tumour with initial presentation in the bone marrow--a clinicopathologic study of 25 adult cases. Hematological oncology 1993;11:35-42.
  • Ringenberg QS, Doll DC, Yarbro JW, Perry MC. Tumors of unknown origin in the bone marrow. Archives of internal medicine 1986;146:2027-8.
  • Ryan RN, Ware WH. Common dental emergencies which may be encountered by the family physician. The Journal of family practice 1975;2:249-53.
  • Fishpool SJ, Tomkinson A. Patterns of hospital admission with epistaxis for 26,725 patients over an 18-year period in Wales, UK. Annals of the Royal College of Surgeons of England 2012;94:559-62.
  • Izak M, Bussel JB. Management of thrombocytopenia. F1000prime reports 2014;6:45.
  • Chou WC, Yeh KY, Peng MT et al. Development and Validation of a Prognostic Score to Predict Survival in Adult Patients With Solid Tumors and Bone Marrow Metastases. Medicine 2015;94:e966.
  • Lee MS, Sanoff HK. Cancer of unknown primary. BMJ (Clinical research ed) 2020;371:m4050.
  • Chandra S, Chandra H, Saini S. Bone marrow metastasis by solid tumors--probable hematological indicators and comparison of bone marrow aspirate, touch imprint and trephine biopsy. Hematology (Amsterdam, Netherlands) 2010;15:368-72.
  • Sar R, Aydogdu I, Ozen S, Sevinc A, Buyukberber S. Metastatic bone marrow tumours: a report of six cases and review of the literature. Haematologia 2001;31:215-23.
There are 16 citations in total.

Details

Primary Language English
Subjects Clinical Sciences
Journal Section Case Report
Authors

Fatma Yalçınkaya 0000-0003-1905-6656

Oğuz Abdullah Uyaroğlu 0000-0003-0440-2026

Early Pub Date August 18, 2021
Publication Date August 18, 2021
Submission Date February 22, 2021
Published in Issue Year 2021 Volume: 12 Issue: 3

Cite

APA Yalçınkaya, F., & Uyaroğlu, O. A. (2021). Common Symptom, Rare Etiology: A Case Metastatic Cancers of Unknown Primary Origin Presenting with Epistaxis and Gingival Bleeding. Journal of Emergency Medicine Case Reports, 12(3), 85-87. https://doi.org/10.33706/jemcr.885104
AMA Yalçınkaya F, Uyaroğlu OA. Common Symptom, Rare Etiology: A Case Metastatic Cancers of Unknown Primary Origin Presenting with Epistaxis and Gingival Bleeding. Journal of Emergency Medicine Case Reports. August 2021;12(3):85-87. doi:10.33706/jemcr.885104
Chicago Yalçınkaya, Fatma, and Oğuz Abdullah Uyaroğlu. “Common Symptom, Rare Etiology: A Case Metastatic Cancers of Unknown Primary Origin Presenting With Epistaxis and Gingival Bleeding”. Journal of Emergency Medicine Case Reports 12, no. 3 (August 2021): 85-87. https://doi.org/10.33706/jemcr.885104.
EndNote Yalçınkaya F, Uyaroğlu OA (August 1, 2021) Common Symptom, Rare Etiology: A Case Metastatic Cancers of Unknown Primary Origin Presenting with Epistaxis and Gingival Bleeding. Journal of Emergency Medicine Case Reports 12 3 85–87.
IEEE F. Yalçınkaya and O. A. Uyaroğlu, “Common Symptom, Rare Etiology: A Case Metastatic Cancers of Unknown Primary Origin Presenting with Epistaxis and Gingival Bleeding”, Journal of Emergency Medicine Case Reports, vol. 12, no. 3, pp. 85–87, 2021, doi: 10.33706/jemcr.885104.
ISNAD Yalçınkaya, Fatma - Uyaroğlu, Oğuz Abdullah. “Common Symptom, Rare Etiology: A Case Metastatic Cancers of Unknown Primary Origin Presenting With Epistaxis and Gingival Bleeding”. Journal of Emergency Medicine Case Reports 12/3 (August 2021), 85-87. https://doi.org/10.33706/jemcr.885104.
JAMA Yalçınkaya F, Uyaroğlu OA. Common Symptom, Rare Etiology: A Case Metastatic Cancers of Unknown Primary Origin Presenting with Epistaxis and Gingival Bleeding. Journal of Emergency Medicine Case Reports. 2021;12:85–87.
MLA Yalçınkaya, Fatma and Oğuz Abdullah Uyaroğlu. “Common Symptom, Rare Etiology: A Case Metastatic Cancers of Unknown Primary Origin Presenting With Epistaxis and Gingival Bleeding”. Journal of Emergency Medicine Case Reports, vol. 12, no. 3, 2021, pp. 85-87, doi:10.33706/jemcr.885104.
Vancouver Yalçınkaya F, Uyaroğlu OA. Common Symptom, Rare Etiology: A Case Metastatic Cancers of Unknown Primary Origin Presenting with Epistaxis and Gingival Bleeding. Journal of Emergency Medicine Case Reports. 2021;12(3):85-7.